vaistinė Žalčia - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 127,403 | 129,299 | 149,623 | 156,483 | 160,792 | 188,453 | 205,999 | 223,806 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 3,122 | 3,390 | 11,478 | 15,084 | 12,438 | 16,251 | 15,246 | 18,123 |
| Equity | 6,322 | 6,588 | 14,766 | 18,390 | 15,748 | 19,562 | 18,558 | 21,441 |
| Liabilities | 9,491 | 6,857 | 8,810 | 5,168 | 6,548 | 10,512 | 5,432 | 14,055 |
| Non-current assets | 262 | 18 | 4 | 360 | 363 | 217 | 643 | 1,822 |
| Current assets | 15,483 | 13,334 | 23,504 | 23,121 | 21,852 | 29,767 | 23,258 | 33,583 |
| Total assets | 15,745 | 13,352 | 23,508 | 23,481 | 22,215 | 29,984 | 23,901 | 35,405 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 16,619 | 20,176 | 21,052 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -1.1% | +1.5% | +15.7% | +4.6% | +2.8% | +17.2% | +9.3% | +8.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 19.8% | 25.4% | 48.8% | 64.2% | 56.0% | 54.2% | 63.8% | 51.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 49.4% | 51.5% | 77.7% | 82.0% | 79.0% | 83.1% | 82.2% | 84.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.5% | 2.6% | 7.7% | 9.6% | 7.7% | 8.6% | 7.4% | 8.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.5 | 1.0 | 0.6 | 0.3 | 0.4 | 0.5 | 0.3 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 31,851 | 33,012 | 37,406 | 38,323 | 48,238 | 62,818 | 68,666 | 74,602 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
vaistinė Žalčia - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-02-18 | 2026-03-01 | 0.04 |
| 2022-09-16 | 2022-10-11 | 0.04 |
vaistinė Žalčia - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-28 | 2026-06-29 | 9.53 |
| 2025-12-01 | 2025-12-28 | 0.86 |
| 2025-11-30 | 2025-11-30 | 0.34 |
| 2025-10-30 | 2025-11-27 | 0.34 |
| 2025-10-02 | 2025-10-23 | 0.34 |
| 2025-04-02 | 2025-04-12 | 0.05 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Žalcia, UAB (code 147860919) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the latest financial year, the company generated revenue of €223.8K and net profit of €18.1K, resulting in a profit margin of 8.1%. Revenue increased by 8.6% year on year and by 18.8% over two years, showing a steady upward trend. Profit also improved versus 2024, after easing slightly from €16.3K in 2023 to €15.2K in 2024 and then rising to €18.1K in 2025. The balance sheet remained compact, with total assets of €35.4K, equity of €21.4K and liabilities of €14.1K at year-end 2025. The equity ratio was 60.6% and debt-to-equity stood at 0.66, indicating a balanced capital structure. Asset turnover was 6.32x, supported by revenue per employee of €74.6K and profit per employee of €6.0K. The business expanded its asset base in 2025, while maintaining profitability and a solid equity position.